Laboratory monitoring of low-molecular-weight heparin therapy--part II. Monitoring LMWH therapy? For the moment a non-question.
Hemker
H C
HC
Synapse BV, Cardiovascular Research Institute, Maastricht, the Netherlands. hc.hemker@thrombin.com
Al Dieri
R
R
Béguin
S
S
D001777:Blood Coagulation / Q000187:drug effects; D016903:Drug Monitoring / Q000379:methods*; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics*; D006801:Humans; D010314:Partial Thromboplastin Time; D013917:Thrombin / Q000037:antagonists & inhibitors
D006495:Heparin, Low-Molecular-Weight; D013917:Thrombin